Jublia Approval History

  • FDA approved: Yes (First approved June 6th, 2014)
  • Brand name: Jublia
  • Generic name: efinaconazole
  • Company: Valeant Pharmaceuticals International, Inc.
  • Treatment for: Onychomycosis, Toenail

Jublia (efinaconazole) is a topical triazole antifungal for the treatment of onychomycosis of the toenails.

FDA Approval History for Jublia

DateArticle
Jun  9, 2014Approval Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis
May 28, 2013Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)